
Reports FY26 revenue $2.3M vs. $2.2M last year. Jeff Kitchell, Chief Executive Officer, stated, “We are up year-over-year despite being a challenging year, with the macro environment causing increased expenses
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PURE | Pure Bioscience | 0.06 | 0.01 | 17.02% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.06 | +17.02% |

Reports FY26 revenue $2.3M vs. $2.2M last year. Jeff Kitchell, Chief Executive Officer, stated, “We are up year-over-year despite being a challenging year, with the macro environment causing increased expenses

Pure Bioscience ( ($PURE) ) has issued an update. On October 15, 2026, PURE Bioscience, Inc. completed a private placement financing with accredited investors, raising $555,000 through the issuance of

Pure Bioscience ( ($PURE) ) has provided an update. On April 30, 2026, PURE Bioscience, Inc. completed a $1.0 million private placement to accredited investors, issuing 18,131,096 common shares at

Pure Bioscience ( ($PURE) ) has provided an update. Pure Bioscience, Inc. held its Annual Meeting of Stockholders on February 17, 2026, with approximately 66% of outstanding shares represented, and

The latest announcement is out from Pure Bioscience ( ($PURE) ). On November 19, 2025, PURE Bioscience, Inc. announced leadership changes effective November 17, 2025, with Jeffrey Kitchell appointed as

PURE Bioscience (PURE) and AFCO, a Zep Company, have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is

PURE Bioscience (PURE) and Madison Chemical Co. have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. Published first on

PURE Bioscience has entered into a multi-year distribution agreement with Tennessee-based Zee Company to purchase and sell PURE‘s patented antimicrobial products. This agreement will allow PURE, the non-toxic Silver Dihydrogen

PURE Bioscience and AgroVet Alliance have entered into a multi-year international supply and license agreement for the purchase and selling of SDC products under special terms and conditions. Published first

Pure Bioscience (PURE) has provided an announcement. Pure Bioscience, Inc. has strengthened its Board of Directors by appointing Darin Zehr, a seasoned executive with extensive experience in the food industry,
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Dec 16, 2026TBA | $7.23M | ― | ― | 6.43 | -2.57 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.